ESMO Congress 2026

October 23–27, 2026 · Madrid · 176 items

UNION

3 people · 3 posts · 2 abstracts

Evidence

3530ONCT04928807

UNION Read the abstract →

NCT04928807NCT04928807

UNION Read the abstract →

Floor

TodayOct 23Fri

Friday · 2 items

07:03
Jeff Ryckman@jryckman3Score6060
UNION: 3y EFS 91% vs 77% with SCRT/CAPOX/camrelizumab vs long-course CRT/CAPOX in rectal cancer. HR 0.33 (95% CI 0.15-0.71). Impressive signal. But RT schedule and IO both changed…
Same topic UNION · 3 people camrelizumabHeat 00 likes0 replies0 reposts
06:02
Krishan Jethwa@KrishanJethwaScore6060
🚨UNION Trial🚨 Locally advanced rectal cancer N=231 🔍Randomized 🔵Chemoradiation➡️2c CAPOX➡️TME➡️6c CAPOX 🟢SCRT➡️2c CAPOX + camrelizumab ➡️TME➡️6c CAPOX+ cam 🔥SCRT + chemo-IO demo…
Same topic UNION · 3 people camrelizumabHeat 85 likes0 replies3 reposts

Oct 19Mon

Monday · 1 items

07:00
DaisukeKotani@DaisukeKotaniScore6060
#ESMO26 | 3530O UNION: Ph3 neoadjuvant SCRT followed by camrelizumab + chemo in locally advanced rectal cancer - 3y-EFS: 91.3% vs 77.4%, HR 0.33, p=0.0029 👉UNION is the first Ph3 …
Same topic UNION · 3 people 3530O camrelizumabHeat 117 likes0 replies4 reposts